Idaho to Receive $438,000 in Settlement with drugmaker Mylan over EpiPen

Business

Share This

BOISE — Idaho will receive approximately $483,000 from EpiPen maker Mylan as part of a federal and multi-state settlement, Attorney General Lawrence Wasden announced Friday.

The settlement resolves allegations Mylan had been overbilling Medicaid programs for the emergency allergy injectors for nearly eight years, according to a news release. Mylan is said to have paid Medicaid too-low rebates for the devices by classifying its brand-name product as a generic, which requires lower rebates.

In order for a drug to be covered by Medicaid, by law pharmaceutical manufacturers agree to rebate a portion of the cost of the drugs given to Medicaid beneficiaries. The companies must also report the lowest price for which it sold a covered drug in a particular quarter, according to a news release.

This marks the second settlement between the U.S. Department of Justice and Mylan since 2009 for allegedly overcharging the government, according to the Associated Press.

If you choose local pickup, please get your gift certificate at our office at 400 W. Sunnyside in Idaho Falls Dismiss